| Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa VC Marconi, H Sunpath, Z Lu, M Gordon, K Koranteng-Apeagyei, ... Clinical infectious diseases 46 (10), 1589-1597, 2008 | 302 | 2008 |
| Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness? T De Oliveira, S Engelbrecht, E Janse van Rensburg, M Gordon, K Bishop, ... Journal of virology 77 (17), 9422-9430, 2003 | 106 | 2003 |
| Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies M Gordon, T De Oliveira, K Bishop, HM Coovadia, L Madurai, ... Journal of virology 77 (4), 2587-2599, 2003 | 104 | 2003 |
| Outcomes after virologic failure of first-line ART in South Africa RA Murphy, H Sunpath, Z Lu, N Chelin, E Losina, M Gordon, D Ross, ... Aids 24 (7), 1007-1012, 2010 | 100 | 2010 |
| High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen H Sunpath, B Wu, M Gordon, J Hampton, B Johnson, MYS Moosa, ... Aids 26 (13), 1679-1684, 2012 | 95 | 2012 |
| Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis B Chimukangara, RJ Lessells, SY Rhee, J Giandhari, ABM Kharsany, ... EClinicalMedicine 9, 26-34, 2019 | 73 | 2019 |
| Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? T De Oliveira, M Salemi, M Gordon, AM Vandamme, EJ van Rensburg, ... Genetics 167 (3), 1047-1058, 2004 | 71 | 2004 |
| Clinical, virologic, immunologic outcomes and emerging HIV drug resistance patterns in children and adolescents in public ART care in Zimbabwe AT Makadzange, M Higgins-Biddle, B Chimukangara, R Birri, M Gordon, ... PloS one 10 (12), e0144057, 2015 | 70 | 2015 |
| HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance N Mbhele, B Chimukangara, M Gordon International journal of antimicrobial agents 57 (5), 106343, 2021 | 65 | 2021 |
| Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium (II)–vanadium (IV) complexes AA Holder, P Taylor, AR Magnusen, ET Moffett, K Meyer, Y Hong, ... Dalton Transactions 42 (33), 11881-11899, 2013 | 52 | 2013 |
| Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic VC Marconi, B Wu, J Hampton, CE Ordónez, BA Johnson, D Singh, ... AIDS patient care and STDs 27 (12), 657-668, 2013 | 51 | 2013 |
| Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid RW Smith, K Downey, M Gordon, A Hudak, R Meeder, S Barker, ... Paediatrics & child health 17 (5), e34-e39, 2012 | 48 | 2012 |
| Tracing the origin of Brazilian HTLV-1 as determined by analysis of host and viral genes LCJ Alcantara, T De Oliveira, M Gordon, O Pybus, RE Mascarenhas, ... Aids 20 (5), 780-782, 2006 | 46 | 2006 |
| The pharmacokinetic properties of HIV-1 protease inhibitors: A computational perspective on herbal phytochemicals I Kehinde, P Ramharack, M Nlooto, M Gordon Heliyon 5 (10), 2019 | 42 | 2019 |
| A systematic review analyzing the prevalence and circulation of influenza viruses in swine population worldwide RP Chauhan, ML Gordon Pathogens 9 (5), 355, 2020 | 41 | 2020 |
| MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu‐Natal, South Africa PK Chelule, M Gordon, T Palanee, T Page, A Mosam, HM Coovadia, ... Clinical Pharmacology & Therapeutics 74 (2), 195-196, 2003 | 39 | 2003 |
| An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates RP Chauhan, ML Gordon Virus Genes 58 (4), 255-269, 2022 | 37 | 2022 |
| Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors F Kayamba, T Malimabe, IK Ademola, OJ Pooe, ND Kushwaha, ... European Journal of Medicinal Chemistry 217, 113330, 2021 | 35 | 2021 |
| Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates HO Ajoge, ML Gordon, T de Oliveira, TN Green, S Ibrahim, OS Shittu, ... PloS one 6 (3), e17865, 2011 | 32 | 2011 |
| Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates HO Ajoge, ML Gordon, T de Oliveira, TN Green, S Ibrahim, OS Shittu, ... PloS one 6 (3), e17865, 2011 | 32 | 2011 |
